May 14, 2021 10:10 PM IST
The construction work has already begun and the government has invited investors to make the vaccine in State.
- May 14, 2021 01:23 PM IST
Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru and Bhuvneshwar, Bharat Biotech Co-Founder and Joint Managing Director Suchitra Ella said in a tweet.
- May 14, 2021 12:10 PM IST
In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.
- May 14, 2021 09:24 AM IST
Covaxin can only be manufactured in the Biosafety level 3 (BSL3) labs, said Dr VK Paul.
- May 13, 2021 06:22 PM IST
While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.
- May 13, 2021 01:49 PM IST
Ella said as many as 18 states received Covaxin though in smaller shipments.
- May 13, 2021 11:01 AM IST
The Drugs Controller General of India (DCGI) has approved Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years.
- May 12, 2021 12:57 PM IST
The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.
- May 11, 2021 06:43 PM IST
The CM said that the average count of cases per day in state over the last seven days stood at 20,300 and as of May 11, the state had 1,86,695 active cases.
- May 10, 2021 12:44 PM IST
The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.
- May 04, 2021 02:23 PM IST
So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.
- May 04, 2021 08:52 AM IST
The B.1.617 variant is also being called a 'double mutant' or the 'Indian strain'.
- May 01, 2021 10:07 AM IST
Covaxin has received Emergency Use Authorisation in several countries across the globe with another 60 in process.
- Apr 29, 2021 05:55 PM IST
Bharat Biotech had earlier set Covaxin’s price at Rs 600 per dose for state governments. The company decided to reduce the price in view of the enormous challenges the second wave of the pandemic has posed for the public healthcare systems.
- Apr 29, 2021 11:51 AM IST
COVID-19 Second Wave Vaccine Drive: It has been a Covishield show so far as state governments make a beeline for developer SII’s office. Bharat Biotech needs to significantly ramp up capacity of Covaxin.
- Apr 28, 2021 01:06 PM IST
The PIL, filed on April 24 by advocate Fayzan Khan and three law students, said the vaccine is presumed to be an essential commodity and hence its management and distribution cannot be left in the hands of private companies.
- Apr 28, 2021 07:53 AM IST
White House chief medical adviser Dr Anthony Fauci said COVID-19 vaccination could be a very important antidote to the pandemic difficulty being seen India.
- Apr 26, 2021 07:41 PM IST
The SII has priced the Covishield vaccine at Rs 400 for states and Rs 600 private hospitals, whereas, the Bharat Biotech has decided to sell the jabs at Rs 600 to states and Rs 1,200 to private hospitals.
- Apr 25, 2021 06:46 PM IST
Former CEA Arvind Subramanian said that centre should bear entire cost of vaccine procurement by state. Other economists partly agree and say that part of the Rs 35,000 crore vaccination budget should be shared with states
- Apr 24, 2021 10:15 PM IST
Bharat Biotech further announced that it will also export Covaxin and the export price of the vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 per dose, approximately.
- Apr 23, 2021 11:16 AM IST
On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.
- Apr 21, 2021 05:08 PM IST
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India.
- Apr 21, 2021 03:19 PM IST
Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 percent against mild, moderate, and severe COVID-19 disease, the company said.
- Apr 20, 2021 03:10 PM IST
The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 700 million doses per year, which are one of the largest production capacities for inactivated viral vaccines worldwide.
- Apr 19, 2021 09:19 PM IST
“The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol